The pharmaceutical industry is currently in a state of flux. The introduction of classic blockbusters is diminishing. At the same time, biotechnology is just beginning to discover its potential. Gene therapy and personalized medicines are further forms of therapy which are showing signs of a promising future. Even now, this paradigm shift is showing a significant effect on automated sterile manufacturing processes.
Aseptic production and manufacturing of pharmaceuticals is per se expensive, and is only then used when either important reasons suggest it, or when it is mandated. Such reasons could include the specific application of the drug, or for reasons of formulation or shelf life.